Skip to main content
. 2023 Jul 6;23:635. doi: 10.1186/s12885-023-11112-w

Fig. 5.

Fig. 5

Pooled results of the median overall survival (mOS) and median progression-free survival (mPFS) with atezolizumab plus bevacizumab. A Pooled results of the mOS. B Pooled results of the mPFS